Wells Fargo’s Prime Medicine PRME Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $250K | Buy |
101,151
+10,332
| +11% | +$25.5K | ﹤0.01% | 4254 |
|
|
2025
Q1 | $181K | Sell |
90,819
-5,362
| -6% | -$10.7K | ﹤0.01% | 4339 |
|
|
2024
Q4 | $281K | Sell |
96,181
-75,287
| -44% | -$220K | ﹤0.01% | 4099 |
|
|
2024
Q3 | $664K | Buy |
171,468
+151,110
| +742% | +$585K | ﹤0.01% | 3460 |
|
|
2024
Q2 | $105K | Buy |
20,358
+8,548
| +72% | +$43.9K | ﹤0.01% | 4554 |
|
|
2024
Q1 | $82.7K | Buy |
11,810
+1,581
| +15% | +$11.1K | ﹤0.01% | 4629 |
|
|
2023
Q4 | $90.6K | Sell |
10,229
-21,088
| -67% | -$187K | ﹤0.01% | 4562 |
|
|
2023
Q3 | $299K | Buy |
31,317
+15,020
| +92% | +$143K | ﹤0.01% | 3814 |
|
|
2023
Q2 | $239K | Buy |
16,297
+14,361
| +742% | +$210K | ﹤0.01% | 4241 |
|
|
2023
Q1 | $23.8K | Buy |
+1,936
| New | +$23.8K | ﹤0.01% | 5254 |
|